Participation in the K-AI China–India Expansion Program

In November 2025, Linkiss participated in the 2025 K-AI China–India Expansion Support Program, held sequentially in Hangzhou (November 16–18) and New Delhi (November 19–22). The program, organized to support Korean AI companies entering these two major markets, offered structured networking, mentorship, and business development opportunities.

Although Hangzhou and New Delhi represent distinct markets, similar core questions emerged at both stops: how does AI translation ensure accuracy in medical contexts, how does the platform protect user data, and what does the onboarding process look like for local clinics or partners?

In Hangzhou, we connected with Chinese tech investors and digital health stakeholders exploring collaborations with Korean AI companies. The conversations reinforced the strong appetite in China for AI-driven healthcare solutions that bridge language and geography.

In New Delhi, meetings with Indian healthtech entrepreneurs and potential distribution partners revealed a significant unmet need for trusted Korean medical tourism facilitation. The K-AI program provided the credibility and structured access that accelerated these conversations, resulting in several promising follow-up engagements.